▶ 調査レポート

ファーマコビジランス及び医薬品安全性ソフトウェアの世界市場:販売、インサイト

• 英文タイトル:Global Pharmacovigilance and Drug Safety Software Sale, Insights Market Research Report 2019-2025

Straits Researchが調査・発行した産業分析レポートです。ファーマコビジランス及び医薬品安全性ソフトウェアの世界市場:販売、インサイト / Global Pharmacovigilance and Drug Safety Software Sale, Insights Market Research Report 2019-2025 / STR-DC033資料のイメージです。• レポートコード:STR-DC033
• 出版社/出版日:Straits Research / 2019年11月28日
• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療IT
• 販売価格(消費税別)
  Single User(1名様用、印刷不可)¥629,000 (USD4,250)▷ お問い合わせ
  Multi User(5名様用)¥836,200 (USD5,650)▷ お問い合わせ
  Enterprise Price(法人閲覧用)¥1,073,000 (USD7,250)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、ファーマコビジランス及び医薬品安全性ソフトウェアの世界市場について調査・分析し、調査手法、市場概要、種類別(医薬品安全性監査ソフトウェア、完全統合ソフトウェア、問題追跡ソフトウェア)分析、エンドユーザー別(製薬およびバイオテクノロジー企業、受託研究機関、ビジネスプロセスアウトソーシング)分析、地域別分析、企業概要などを含め次の構成でお届け致します。

・イントロダクション
・調査手法
・市場概要
・ファーマコビジランス及び医薬品安全性ソフトウェアの世界市場:種類別(医薬品安全性監査ソフトウェア、完全統合ソフトウェア、問題追跡ソフトウェア)
・ファーマコビジランス及び医薬品安全性ソフトウェアの世界市場:エンドユーザー別(製薬およびバイオテクノロジー企業、受託研究機関、ビジネスプロセスアウトソーシング)
・ファーマコビジランス及び医薬品安全性ソフトウェアの世界市場:地域別
・企業概要

Global pharmacovigilance and drug safety software market is expected to reach USD 243.1 million in 2026 from USD 145.9 million in 2018 at a CAGR of 6.7% during the forecast period 2019–2026

Pharmacovigilance is the detection, assessment, understanding, and prevention of adverse drug reactions (ADR’s), severe adverse events (SAE’s), or severe events (SE’s) through a set of activities including data collection. Pharmacovigilance and drug safety software are generally used to identify the causes of withdrawal regarding drugs and prevent unnecessary future adverse events. It is beneficial to everyone concerned with the medical process, including consumers, prescribers, and makers for increasing efficacy of the pharmacovigilance process coupled with increasing drug safety.

Today, the number of casualties occurring due to medical errors is increasing at an alarming rate. Globally, around 142,000 people died in 2013 from adverse effects of medical errors, which increased from 94000 in 1990. In the U.S. alone, 251,454 people died due to faults in medical treatments in 2013, WHO. It is estimated that medical errors result in between 44,000 and 98,000 preventable deaths and 1 million excess injuries each year in the U.S hospitals.

Role of Drug Safety Audits Software in Pharmacovigilance and Drug Safety Software Market
For better understand, we have segmented the global pharmacovigilance and drug safety software market by type and end-user.

By type, the market is further segmented into drug safety audits software, fully integrated software, and issue tracking software. Drug safety audits software is expected to account for a significant share of the global pharmacovigilance and drug safety software market and is anticipated to exhibit profitable growth, which can be attributed to its ability to monitor and track serious adverse events, serious & non-serious adverse drug reactions, and medically related product information. Moreover, growing number of clinical trials and increasing pressure from the government authorities such as European Medicines Agency and the U.S. Food & Drug Administration (FDA) to follow and comply with safety guidelines are expected to contribute to the growing adoption of drug safety audits software. The drug safety audit software segment was valued at USD 68.36 million in 2014.

The fully integrated software segment is expecting a steady growth in the global pharmacovigilance and drug safety software market. This can be attributed to its accuracy to avoid data redundancy by eliminating errors and tracking individual case safety reports. Moreover, a rise in the demand for fully integrated software across the globe for pharmacovigilance and data safety solutions is expected to support the market growth. The fully integrated software segment was valued at USD 13.82 million in 2014 and is likely to reach USD 14.99 million by the end of 2019.

By end-user, the global pharmacovigilance and drug safety software market is segmented into pharma and biotech companies, contract research organizations, and business process outsourcing.

Increasing research & development activities by the major pharmaceutical and biotechnology companies are driving the growth of the pharma & biotech company. Additionally, rising number of new and improved drugs in the pipeline and clinical trials need pharmacovigilance services, which is further contributing to the market growth. Pharma and biotech companies were valued at USD 19.93 million in 2014, and it reaches USD 24.27 million by 2019.

Contract Research Organizations are actively participating in the research & development activities following the rising prevalence of chronic diseases across the globe. Moreover, active participation of the CRO’s in research & development is pushing the overall growth further. Contract Research Organizations was valued at USD 49.37 million in 2014, and it increased to USD 66.91 million by 2019.

North America Pharmacovigilance and Drug Safety Software Market to grow at a CAGR of 5%
Global Pharmacovigilance and drug safety software market is segmented into North America, Europe, Asia Pacific, and the Middle East and Africa.

North America is witnessing a strong growth in the market following the robust research & development activities on the drugs for treating severe and chronic diseases. Moreover, rising prevalence of chronic diseases from the last two decades has developed the demand for research & development to find a cure. Growing number of cancer cases is a dire concern of this region. For instance, more than 1.7 million new cases of cancer were registered in the U.S. in 2018, National Care Institute. Whereas in Canada, it was estimated that over 206,200 new cases of cancer were registered in 2017, Canada Cancer Society. North American pharmacovigilance and drug safety software was valued at USD 53.08 million in 2014 and is expected to grow at a CAGR of 5% during the forecast period 2016–2026.

Europe is the second leading region in the global pharmacovigilance and drug safety software market and is likely to continue the same during the forecast period 2016–2026. This can be attributed to increasing research & development activities to find a cure for several chronic diseases including neurological disorders such as epilepsy, schizophrenia, bipolar disorders, and seizures experienced in epilepsy by pharmaceutical and biotechnology industries. For instance, over 500,000 people are living with epilepsy with a daily incidence rate of approximately 87 people, Epilepsy Society. Moreover, rising incidences of other severe diseases, including cardiovascular diseases and arthritis across Europe is likely to boost the demand for pharmacovigilance and drug safety software market. In this region, the market was valued at USD 42.8 million in 2014 and is projected to grow at a CAGR of 6.2%.

Asia Pacific is witnessing significant growth in the global pharmacovigilance and drug safety software market on account of rising geriatric population and increasing prevalence of chronic diseases in the region. China is experiencing swift growth in the pharmacovigilance and drug safety software market as a result of ongoing development in the pharmacovigilance, geriatric population and prevalence of chronic diseases. For treating chronic and severe diseases such as gastrointestinal disorders, oncology, and neurology numerous Japanese companies are investing significantly in research and development. Currently, the country has several drugs in pipeline for treating these diseases.

Middle East is emerging in the pharmacovigilance and drug safety software market. This can be accredited to increasing research & development activities in the region. Moreover, African market is struggling to pace up the growth as a result poor healthcare infrastructure and sluggish economic growth in this region.

Prominent Players Active in the Market
Some of the key players in the pharmacovigilance and drug safety software market Sarjan Systems Pvt Ltd, Sparta Systems INC, United BioSource Corporation, Oracle Corporation, Online Business Application INC, and EXTEBO Gmbh.

Our Report Covers
• Historical inferences, findings & analysis of the market from 2016 to 2018
• Projections and performance forecast analysis for the future from 2019 to 2026
• Production and consumption point of view (POV) analysis
• Market drivers, restraint and opportunity analysis, to define market dynamics covering industry, regulatory, innovation, technological & pricing trends
• Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability, and prospects

レポート目次

TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Pharmacovigilance and Drug Safety Software Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
4 Type Overview
4.1 Introduction
4.1.1 Market Size & Forecast
4.2 Drug Safety Audits Software
4.2.1 Market Size & Forecast
4.3 Fully Integrated Software
4.3.1 Market Size & Forecast
4.3 Issue Tracking Software
4.3.1 Market Size & Forecast
5 End-users Overview
5.1 Introduction
5.1.1 Market Size & Forecast
5.2 Pharma and Biotech Companies
5.2.1 Market Size & Forecast
5.3 Contract Research Organizations
5.3.1 Market Size & Forecast
5.4 Business Process Outsourcing
5.4.1 Market Size & Forecast
6 Regional Overview
6.1 Introduction
6.1.1 Market Size & Forecast
6.2 Americas
6.2.1 North America
6.2.1.1 The U.S.
6.2.1.1.1 By type
6.2.1.1.2 By end – users
6.2.1.2 Canada
6.2.1.2.1 By type
6.2.1.2.2 By end – users
6.2.1.3 Mexico
6.2.1.3.1 By type
6.2.1.3.2 By end – users
6.2.2 South America
6.2.2.1 By type
6.2.2.2 By end – users
6.3 Europe
6.3.1 Market Size & Forecast
6.3.2 Western Europe
6.3.2.1 Germany
6.3.2.1.1 By type
6.3.2.1.2 By end – users
6.3.2.2 France
6.3.2.2.1 By type
6.3.2.2.2 By end – users
6.3.2.3. U.K.
6.3.2.3.1 By type
6.3.2.3.2 By end – users
6.3.2.4 Spain
6.3.2.4.1 By type
6.3.2.4.2 By end – users
6.3.2.5 Italy
6.3.2.5.1 By type
6.3.2.5.2 By end – users
6.3.2.6 Rest of Western Europe
6.3.2.6.1 By type
6.3.2.6.2 By end – users
6.3.3 Eastern Europe
6.3.3.1 By type
6.3.3.2 By end – users
6.4 Asia Pacific
6.4.1 Market Size & Forecast
6.4.2 Japan
6.4.2.1 By type
6.4.2.2 By end – users
6.4.3 China
6.4.3.1 By type
6.4.3.2 By end – users
6.4.4 Australia
6.4.4.1 By type
6.4.4.2 By end – users
6.4.5 India
6.4.5.1 By type
6.4.5.2 By end – users
6.4.6 South Korea
6.4.6.1 By type
6.4.6.2 By end – users
6.4.7 Rest of Asia-Pacific
6.4.7.1 By type
6.4.7.2 By end – users
6.5 Middle East & Africa
6.5.1 Market Size & Forecast
6.5.2 Saudi Arabia
6.5.2.1 By type
6.5.2.2 By end – users
6.5.3 South Africa
6.5.3.1 By type
6.5.3.2 By end – users
6.5.4 Rest of Middle East & Africa
6.5.4.1 By type
6.5.4.2 By end – users
7 Company Profile
7.1 Sarjan Systems Pvt Ltd
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Recent Developments
7.1.4 Services Portfolio
7.2 Sparta Systems INC
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Recent Developments
7.2.4 Services Portfolio
7.3 United BioSource Corporation
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Recent Developments
7.3.4 Services Portfolio
7.4 Oracle Corporation
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Recent Developments
7.4.4 Services Portfolio
7.5 Online Business Application INC
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Recent Developments
7.5.4 Services Portfolio
7.6 EXTEBO Gmbh
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Recent Developments
7.6.4 Services Portfolio
7.7 ArisGlobal
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Recent Developments
7.7.4 Services Portfolio
7.8 Ennov Solutions Inc
7. 8.1 Company Overview
7. 8.2 Financial Performance
7. 8.3 Recent Developments
7. 8.4 Services Portfolio

LIST OF TABLES
TABLE 1 Global Pharmacovigilance and Drug Safety Software Market Share, By Type, 2016 – 2026 ($Million)
TABLE 2 Drug Safety Audits Software, Market Share, By Region, 2016 – 2026, ($ Million)
TABLE 3 Fully Integrated Software, Market Share, By Region, 2016 – 2026, ($ Million)
TABLE 4 Issue Tracking Software, Market Share, By Region, 2016 – 2026, ($ Million)
TABLE 5 Global Pharmacovigilance and Drug Safety Software Market Share, By End - users, 2016 – 2026 ($Million)
TABLE 6 Pharma and Biotech Companies, Market Share, By Region, 2016 – 2026, ($ Million)
TABLE 7 Contract Research Organizations, Market Share, By Region, 2016 – 2026, ($ Million)
TABLE 8 Business Process Outsourcing, Market Share, By Region, 2016 – 2026, ($ Million)
TABLE 9 America Global Pharmacovigilance and Drug Safety Software Market Share Value, By Region, 2016 – 2026 ($Million)
TABLE 10 America Pharmacovigilance and Drug Safety Software Market Share value, By Type, 2016-2026 ($Million)
TABLE 11 America Pharmacovigilance and Drug Safety Software Market Share value, By End - users, 2016-2026 ($Million)
TABLE 12 North America Pharmacovigilance and Drug Safety Software Market Share value, By Country, 2016-2026 ($Million)
TABLE 13 North America Pharmacovigilance and Drug Safety Software Market Share value, By Type, 2016-2026 ($Million)
TABLE 14 North America Pharmacovigilance and Drug Safety Software Market Share value, By End - users, 2016-2026 ($Million)
TABLE 15 U.S. Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 16 U.S. Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 17 Canada Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 18 Canada Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 19 Mexico Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 20 Mexico Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 21 South America Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 22 South America Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 23 Europe Pharmacovigilance and Drug Safety Software Market Share Value, By Region, 2016 – 2026 ($Million)
TABLE 24 Europe Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 25 Europe Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 26 Western Europe Pharmacovigilance and Drug Safety Software Market Share Value, By Country, 2016 – 2026 ($Million)
TABLE 27 Western Europe Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 28 Western Europe Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 29 Germany Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 30 Germany Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 31 France Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 32 France Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 33 U.K. Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 34 U.K. Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 35 Italy Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 36 Italy Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 37 Spain Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 38 Spain Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 39 Rest of Western Europe Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 40 Rest of Western Europe Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 41 Eastern Europe Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 42 Eastern Europe Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 43 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Share Value, By Country, 2016 – 2026 ($Million)
TABLE 44 Asia-Pacific Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 45 Asia-Pacific Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 46 Japan Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 47 Japan Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 48 China Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 49 China Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 50 Australia Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 51 Australia Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 52 India Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 53 India Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 54 South Korea Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 55 South Korea Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 56 Rest of Asia-pacific Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 57 Rest of Asia-pacific Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 58 MEA Pharmacovigilance and Drug Safety Software Market Share Value, By Region, 2016 – 2026 ($Million)
TABLE 59 MEA Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 60 MEA Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 61 Saudi Arabia Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 62 Saudi Arabia Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 63 South Africa Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 64 South Africa Pharmacovigilance and Drug Safety Software Market share, By End - users, 2016-2026 ($Million)
TABLE 65 Rest of MEA Pharmacovigilance and Drug Safety Software Market share, By Type, 2016-2026 ($Million)
TABLE 66 Rest of MEA Pharmacovigilance and Drug Safety Software Market share, By end - users, 2016-2026 ($Million) 
List of Figures
FIGURE 1 Global Pharmacovigilance and Drug Safety Software Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Global Pharmacovigilance and Drug Safety Software Market, 2016-2026
FIGURE 9 Americas Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 10 North America Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 11 U.S. Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 12 Canada Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 13 Mexico Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 14 South America Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 15 Europe Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 16 Western Europe Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 17 Germany Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 18 France Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 19 UK Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 20 Italy Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 21 Spain Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 22 Rest of Western Europe Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 23 Eastern Europe Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 24 Asia Pacific Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 25 Japan Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 26 China Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 27 Australia Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 28 India Global Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 29 South Korea Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 30 Rest of Asia-pacific Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 31 MEA Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 32 Saudi Arabia Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 33 South Africa Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 34 Rest of MEA Pharmacovigilance and Drug Safety Software Market Share, 2016-2026 ($Million)
FIGURE 35 ArisGlobal.: Revenue Analysis, ($ million)
FIGURE 36 ArisGlobal.: Segment Revenue 2017 (%)